These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29554088)

  • 1. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
    Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
    PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
    Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
    Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a novel combination of TRAM-34 and ascorbic acid for the treatment of corneal fibrosis in vivo.
    Fuchs AA; Balne PK; Giuliano EA; Sinha NR; Mohan RR
    PLoS One; 2022; 17(1):e0262046. PubMed ID: 35007294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of KCa3.1: A novel target to treat TGF-β1 induced conjunctival fibrosis.
    Anumanthan G; Wilson PJ; Tripathi R; Hesemann NP; Mohan RR
    Exp Eye Res; 2018 Feb; 167():140-144. PubMed ID: 29242028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
    Xie H; Lu J; Zhu Y; Meng X; Wang R
    Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.
    Huang C; Shen S; Ma Q; Gill A; Pollock CA; Chen XM
    Nephrol Dial Transplant; 2014 Feb; 29(2):313-24. PubMed ID: 24166472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered K
    Seo CH; Cui HS; Kim JB
    Transl Res; 2021 Oct; 236():133-146. PubMed ID: 33905948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.
    Roach KM; Wulff H; Feghali-Bostwick C; Amrani Y; Bradding P
    Respir Res; 2014 Dec; 15(1):155. PubMed ID: 25476248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
    Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of KCa3.1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction.
    Ju CH; Wang XP; Gao CY; Zhang SX; Ma XH; Liu C
    Cell Physiol Biochem; 2015; 36(4):1305-15. PubMed ID: 26160442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
    Zhang Y; Feng Y; Chen L; Zhu J
    Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of
    Gupta S; Martin LM; Sinha NR; Smith KE; Sinha PR; Dailey EM; Hesemann NP; Mohan RR
    Mol Vis; 2020; 26():742-756. PubMed ID: 33273801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.
    Grgic I; Kiss E; Kaistha BP; Busch C; Kloss M; Sautter J; Müller A; Kaistha A; Schmidt C; Raman G; Wulff H; Strutz F; Gröne HJ; Köhler R; Hoyer J
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14518-23. PubMed ID: 19706538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
    Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
    Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine decreases formation of myofibroblasts and excessive extracellular matrix production in an in vitro human corneal fibrosis model.
    Słoniecka M; Danielson P
    J Cell Mol Med; 2020 Apr; 24(8):4850-4862. PubMed ID: 32176460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
    Freise C; Querfeld U
    Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis.
    Roach KM; Duffy SM; Coward W; Feghali-Bostwick C; Wulff H; Bradding P
    PLoS One; 2013; 8(12):e85244. PubMed ID: 24392001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
    Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K
    Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
    Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.